Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Grade 1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT02579772
What this trial is testing

Effects of N-acetylcysteine on Cardiorespiratory Control in COPD Patients With Mild-to-moderate Airflow Obstruction

Who this might be right for
Pulmonary Disease, Chronic Obstructive
Queen's University 13
Not applicableStudy completedNCT06367231
What this trial is testing

SCGs as a Proxy for Determining the Cognitive Status of Older Adults

Who this might be right for
Mild Cognitive ImpairmentDementiaAlzheimer Disease+2 more
University of Alberta 6
Not applicableUnknownNCT02100202
What this trial is testing

Efficacy and Safety Study of Dietary Supplements in Chronic Smokers Having Mild to Moderate Hyperlipidemia

Who this might be right for
Chronic SmokersHyperlipidemia
Olive Lifesciences Pvt Ltd 60
Not applicableNot Yet RecruitingNCT07374653
What this trial is testing

Online Self-healing Program

Who this might be right for
Mild to Moderate Depressive Symptoms
City University of Hong Kong 200
Early research (Phase 1)Study completedNCT03681457
What this trial is testing

Evaluation of the Pharmacokinetics of Tropifexor in Subjects With Mild, Moderate, or Severe Hepatic Impairment Compared to Healthy Control Subjects

Who this might be right for
Non-alcoholic Fatty Liver Disease
Novartis Pharmaceuticals 42
Testing effectiveness (Phase 2)UnknownNCT05947812
What this trial is testing

A Clinical Evaluation of the Safety and Efficacy of Randomized Placebo Versus the 8-aminoquinoline Tafenoquine for Early Symptom Resolution in Patients With Mild to Moderate COVID 19 Disease and Low Risk of Disease Progression

Who this might be right for
COVID 19 DiseaseMild to Moderate COVID 19 DiseaseSARS-CoV-2+2 more
60P Australia Pty Ltd 148
Testing effectiveness (Phase 2)Ended earlyNCT00112723
What this trial is testing

Flavopiridol in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma

Who this might be right for
Adult Lymphocyte Depletion Hodgkin LymphomaAdult Lymphocyte Predominant Hodgkin LymphomaAdult Mixed Cellularity Hodgkin Lymphoma+25 more
National Cancer Institute (NCI) 46
Testing effectiveness (Phase 2)Looking for participantsNCT06637423
What this trial is testing

A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)

Who this might be right for
Non-Muscle Invasive Bladder Cancer
Merck Sharp & Dohme LLC 32
Testing effectiveness (Phase 2)Study completedNCT05432596
What this trial is testing

Study of ATI-1777 in Patients 12 to 65 Years Old With Mild to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Aclaris Therapeutics, Inc. 250
Testing effectiveness (Phase 2)Study completedNCT03725722
What this trial is testing

Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over an 8-week Treatment Period in Adult Subjects With Atopic Dermatitis.

Who this might be right for
Atopic Dermatitis
LEO Pharma 251
Testing effectiveness (Phase 2)Ended earlyNCT01013870
What this trial is testing

Mission Connect Mild Traumatic Brain Injury (TBI) Integrated Clinical Protocol

Who this might be right for
Traumatic Brain InjuryPost-traumatic Stress Disorder
Baylor College of Medicine 52
Not applicableStudy completedNCT04206670
What this trial is testing

In-Home Technology for Caregivers of People With Dementia and Mild Cognitive Impairment

Who this might be right for
DementiaMild Cognitive ImpairmentAlzheimer Disease
University of California, Berkeley 216
Not applicableLooking for participantsNCT02537769
What this trial is testing

Study of the Clinical Impact of Surgical Correction of Tricuspid Insufficiency in Implantable LVAD Patients

Who this might be right for
Tricuspid RegurgitationHeart Failure NYHA Class IIIHeart Failure NYHA Class IV
University of Washington 40
Not applicableStudy completedNCT05844241
What this trial is testing

The Effect of Auditory Interventions on Anxiety and Agitation in People With Dementia

Who this might be right for
Mild to Moderate Dementia
Lucid, Inc. 48
Not applicableLooking for participantsNCT06246929
What this trial is testing

Healthy Aging as Black Adults, In It Together: a Comparative Effectiveness Study of Chronic Pain and Cognitive Decline

Who this might be right for
Chronic PainPhysical ActivityOlder Adults+1 more
Massachusetts General Hospital 400
Not applicableEnded earlyNCT03929302
What this trial is testing

Brain Energy Metabolism and Sleep in Adults

Who this might be right for
Alzheimer DiseaseMild Cognitive ImpairmentCognitive Change+2 more
The University of Texas at Dallas 41
Large-scale testing (Phase 3)Study completedNCT00000173
What this trial is testing

Memory Impairment Study (Mild Cognitive Impairment Study)

Who this might be right for
Alzheimer Disease
National Institute on Aging (NIA)
Large-scale testing (Phase 3)Study completedNCT05385770
What this trial is testing

Study to Evaluate and Compare the Efficacy and Safety of AZM and AML Combined and Alone in Mild-to-moderate Essential Hypertensive Subjects

Who this might be right for
Essential Hypertension
Celltrion 890
Not applicableUnknownNCT00631254
What this trial is testing

CysLT1-r Expression Following Allergen Exposure in Asthma and Allergic Rhinitis

Who this might be right for
AsthmaAllergic Rhinitis
Laval University 30
Not applicableStudy completedNCT01381705
What this trial is testing

Biomarkers in Predicting Response to Rituximab Treatment in Samples From Patients With Indolent Follicular Lymphoma

Who this might be right for
Lymphoma
ECOG-ACRIN Cancer Research Group 259
Next Page